Mirum Pharmaceuticals Inc (MIRM)
24.07
-0.68
(-2.75%)
USD |
NASDAQ |
May 17, 16:00
24.07
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Free Cash Flow: -42.04M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -42.04M |
| December 31, 2023 | -91.05M |
| September 30, 2023 | -103.95M |
| June 30, 2023 | -111.77M |
| March 31, 2023 | -114.56M |
| December 31, 2022 | -120.41M |
| September 30, 2022 | -138.05M |
| June 30, 2022 | -146.23M |
| March 31, 2022 | -166.24M |
| Date | Value |
|---|---|
| December 31, 2021 | -151.78M |
| September 30, 2021 | -135.94M |
| June 30, 2021 | -119.22M |
| March 31, 2021 | -96.06M |
| December 31, 2020 | -89.30M |
| September 30, 2020 | -66.76M |
| June 30, 2020 | -64.65M |
| March 31, 2020 | -55.62M |
| December 31, 2019 | -39.64M |
Free Cash Flow Range, Past 5 Years
-166.24M
Minimum
Mar 2022
-39.64M
Maximum
Dec 2019
-102.96M
Average
-107.86M
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals Inc | -11.77M |
| Sarepta Therapeutics Inc | -653.88M |
| Puma Biotechnology Inc | 35.61M |
| Reneo Pharmaceuticals Inc | -75.65M |
| Tharimmune Inc | -6.661M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 15.21M |
| Cash from Investing (Quarterly) | -0.013M |
| Cash from Financing (Quarterly) | 1.205M |
| Free Cash Flow Per Share (Quarterly) | 0.3239 |
| Free Cash Flow to Equity (Quarterly) | 14.78M |
| Free Cash Flow to Firm (Quarterly) | 15.20M |
| Free Cash Flow Yield | -4.04% |